Advertisement

Pharmacy World & Science

, Volume 32, Issue 2, pp 194–199 | Cite as

Clinical pharmacists’ interventions in a German University Hospital

  • Claudia LangebrakeEmail author
  • Heike Hilgarth
Research Article

Abstract

Objective To evaluate pharmaceutical interventions by ward-based clinical pharmacists in Germany. Setting Two ward-based clinical pharmacists working at the Departments of Stem Cell Transplantation and Intensive Care Medicine. Methods Pharmaceutical interventions during ward rounds from December 1st 2006 to November 30th 2008 were recorded and classified according to our own system that was adopted from established classification systems. Main outcome measure Classification of (1) cause of intervention, (2) intervention, (3) outcome of intervention and (4) initiator of intervention. Results Altogether 2,312 interventions were documented. Besides 520 cases of information about drugs (rational selection, occurrence of infrequent adverse events or interactions), the main interventions were recommendations for the addition, the withdrawal or the replacement of a drug (n = 907, 50.6%) and advices for the change of dosage, dosing intervals or dose adjustment according to impaired renal or liver function (n = 584, 32.6%). The vast majority of the suggested interventions (92.8%) have been accepted. Conclusion The participation of a clinical pharmacist during ward rounds contributes to the optimisation of pharmacotherapy, in terms of choosing the most appropriate drug and/or the suitable dosage and may improve patient care.

Keywords

Classification Clinical pharmacist Germany Hospital pharmacy Pharmaceutical intervention Pharmacotherapy 

Notes

Acknowledgments

We want to thank Prof. Dr. med. Georg Kreymann, Prof. Dr. med. Axel R. Zander and Dr. Michael Baehr, who initiated the project “Clinical Pharmacists” at our hospital for the fruitful cooperation at all times.

Funding

There was no external funding obtained for this work.

Conflicts of interest

There are no conflicts of interest to be stated.

References

  1. 1.
    Surugue J, Vulto AG. Workforce of EU hospitals and pharmacy services: a direct patient safety issue. EJHP Pract. 2006;12:31–3.Google Scholar
  2. 2.
    Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955–64.CrossRefPubMedGoogle Scholar
  3. 3.
    Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102:275–80.CrossRefPubMedGoogle Scholar
  4. 4.
    Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.CrossRefPubMedGoogle Scholar
  6. 6.
    Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy. 2006;26:735–47.CrossRefPubMedGoogle Scholar
  7. 7.
    Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27:481–93.CrossRefPubMedGoogle Scholar
  8. 8.
    Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm. 2007;64:842–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Tonna AP, Stewart D, West B, Gould I, McCaig D. Antimicrobial optimisation in secondary care: the pharmacist as part of a multidisciplinary antimicrobial programme—a literature review. Int J Antimicrob Agents. 2008;31:511–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Heyde C, Rutsch A, Eschke D. Clinical pharmacists increase the safety of drug therapy at the time of admission. Krankenhauspharmazie. 2009;30:215–7.Google Scholar
  11. 11.
    Walk SU, Fritz S, Pruszydlo MG, Hartwig W, Haefeli WE, Hoppe-Tichy T. Pharmaceutical counselling of drug switches at the interface between primary and tertiary care. Krankenhauspharmazie. 2009;30:218–21.Google Scholar
  12. 12.
    Frey OR. Therapeutic drug monitoring. Krankenhauspharmazie. 2009;30:222–4.Google Scholar
  13. 13.
    Hartmann A, Eberhardt T, Brüggmann J. Dose individualization in patients with renal insufficiency. Krankenhauspharmazie. 2009;30:225–9.Google Scholar
  14. 14.
    Krämer I. Pharmacist-conducted patient education and compliance enhancement in specific patient groups. Krankenhauspharmazie. 2009;30:230–5.Google Scholar
  15. 15.
    Sattler A. Pharmaceutical care with SOAP-notes. Krankenhauspharmazie. 2009;30:239–41.Google Scholar
  16. 16.
    Probst W. Benefit of pharmaceutical care in patients feeded via enteral tube. Krankenhauspharmazie. 2009;30:248–50.Google Scholar
  17. 17.
    Neubauer W, Hug MJ, Bertz H, Strehl E, Engelhardt M. The role of the pharmacist in the development of clinical guidelines. Krankenhauspharmazie. 2009;30:255–8.Google Scholar
  18. 18.
    Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med. 2000;28:3746–50.CrossRefPubMedGoogle Scholar
  19. 19.
    Langebrake C, Hilgarth H. Clinical pharmacy at the University Medical Centre Hamburg-Eppendorf. Krankenhauspharmazie. 2008;29:83–9.Google Scholar
  20. 20.
    Pharmaceutical Care Network Europe. PCNE classification for drug-related problems V5.01. 2008. http://www.pcne.org/. Accessed 30 Jul 2008.
  21. 21.
    Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci. 2002;24:120–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30:379–407.CrossRefPubMedGoogle Scholar
  23. 23.
    Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002;58:285–91.CrossRefPubMedGoogle Scholar
  24. 24.
    Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168:687–94.CrossRefPubMedGoogle Scholar
  25. 25.
    Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med. 2001;16:369–75.CrossRefPubMedGoogle Scholar
  26. 26.
    Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients. Am J Health Syst Pharm. 2007;64:1935–42.CrossRefPubMedGoogle Scholar
  27. 27.
    Klopfer JD, Einarson TR. Acceptance of pharmacists’ suggestions by prescribers: a literature review. Hosp Pharm. 1990;25:830–6.PubMedGoogle Scholar
  28. 28.
    Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy. 2003;23:113–32.CrossRefPubMedGoogle Scholar
  29. 29.
    Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy. 2002;22:134–47.CrossRefPubMedGoogle Scholar
  30. 30.
    Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691–8.PubMedGoogle Scholar
  31. 31.
    Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64:2483–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Kantelhardt P, Langebrake C. DokuPIK—a new database for the documentation of medication errors and pharmaceutical interventions (part I medication errors). Krankenhauspharmazie. 2009;30:63–8.Google Scholar
  33. 33.
    Langebrake C, Kantelhardt P. DokuPIK—a new database for the documentation of medication errors and pharmaceutical interventions (part II interventions). Krankenhauspharmazie. 2009;30:149–55.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Department of Stem Cell Transplantation and PharmacyUniversity Medical Centre Hamburg-EppendorfHamburgGermany
  2. 2.Department of Intensive Care Medicine and PharmacyUniversity Medical Centre Hamburg-EppendorfHamburgGermany

Personalised recommendations